Chunming Zhang Selected Research

Paxillin

1/2012

Fascin-1, ezrin and paxillin contribute to the malignant progression and are predictors of clinical prognosis in laryngeal squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chunming Zhang Research Topics

Disease

17	Neoplasms (Cancer) 02/2024 - 05/2008
8	Squamous Cell Carcinoma of Head and Neck 04/2024 - 01/2012
3	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2012
3	Carcinogenesis 01/2023 - 11/2019
3	Laryngeal Neoplasms (Laryngeal Cancer) 09/2022 - 12/2013
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2023 - 12/2013
2	COVID-19 01/2023 - 12/2020
2	Hypertension (High Blood Pressure) 01/2023 - 12/2020
2	Carcinoma (Carcinomatosis) 09/2022 - 10/2013
2	Lymphatic Metastasis 01/2012 - 05/2008
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2024
1	Pathologic Processes 09/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023
1	Thyroid Neoplasms (Thyroid Cancer) 01/2023
1	Dyslipidemias (Dyslipidemia) 01/2023
1	Chondrosarcoma 01/2023
1	Non-alcoholic Fatty Liver Disease 01/2023
1	Erectile Dysfunction 01/2023
1	Infertility (Sterility) 01/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2023
1	Sarcoma (Soft Tissue Sarcoma) 01/2023
1	Osteosarcoma (Osteogenic Sarcoma) 01/2023
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022
1	Dizziness (Lightheadedness) 01/2022
1	Obesity 01/2022
1	Polyps 01/2021
1	Infections 12/2020
1	Cytokine Release Syndrome 12/2020
1	Inflammation (Inflammations) 10/2018
1	Spinal Cord Injuries (Spinal Cord Injury) 10/2018
1	Papillary Thyroid Cancer 07/2017
1	Cysts 01/2015
1	Allergic Rhinitis 07/2011

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2012
5	Long Noncoding RNAIBA 10/2023 - 07/2017
5	MicroRNAs (MicroRNA)IBA 09/2023 - 10/2013
2	fascinIBA 04/2024 - 11/2019
2	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 12/2013
2	Biomarkers (Surrogate Marker)IBA 10/2023 - 07/2017
2	Circular RNAIBA 09/2023 - 07/2023
2	CarbonIBA 01/2022 - 01/2015
2	CytokinesIBA 12/2020 - 07/2011
2	Messenger RNA (mRNA)IBA 07/2011 - 05/2008
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2024
1	Activins (Activin)IBA 02/2024
1	Activin Receptors (Activin Receptor)IBA 02/2024
1	6-methyladenineIBA 12/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	Triglycerides (Triacylglycerol)IBA 01/2023
1	VaccinesIBA 01/2023
1	7,3'-dihydroxy-4'-methoxyisoflavoneIBA 01/2023
1	GANT 61IBA 01/2023
1	Class 4 Receptor-Like Protein Tyrosine PhosphatasesIBA 01/2023
1	Death Domain ReceptorsIBA 01/2023
1	oxidized low density lipoproteinIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Transfer RNA (tRNA)IBA 01/2023
1	Gly Transfer RNAIBA 01/2023
1	Sincalide FDA Link 01/2022
1	IronIBA 01/2022
1	SulfurIBA 01/2022
1	Explosive Agents (Explosives)IBA 01/2022
1	16S Ribosomal RNAIBA 01/2021
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2021
1	Angiotensin-Converting Enzyme 2IBA 12/2020
1	Angiotensin Receptor AntagonistsIBA 12/2020
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Dinoprostone (PGE2)FDA Link 10/2018
1	Oxygen (Dioxygen)IBA 01/2015
1	Cetuximab (Erbitux)FDA Link 12/2013
1	ezrinIBA 01/2012
1	PaxillinIBA 01/2012
1	Member 3 Group F Nuclear Receptor Subfamily 1IBA 07/2011
1	OvalbuminIBA 07/2011
1	Interleukin-17 (Interleukin 17)IBA 07/2011
1	Interleukin-4 (Interleukin 4)IBA 07/2011
1	Vascular Endothelial Growth Factor CIBA 05/2008
1	N 30IBA 05/2008

Therapy/Procedure

3	Therapeutics 02/2024 - 01/2022
3	Drug Therapy (Chemotherapy) 01/2023 - 12/2013
2	Radiotherapy 01/2023 - 12/2013
2	Chemoradiotherapy 09/2022 - 03/2014
1	Art Therapy 01/2023
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2023